Advertisement
There is considerable variation in the use of rehabilitation services in the acute care setting following ischemic stroke

Use of Rehab After Ischemic Stroke Varies in Acute Care

0
Some stroke patients less likely to get rehabilitation services due to patient, hospital variables
Fournier gangrene is a safety concern for adults with diabetes receiving treatment with sodium-glucose cotransporter-2 inhibitors

Fournier Gangrene Is Safety Concern With SGLT2 Inhibitors

0
FDA identified 55 cases of FG in patients on SGLT2 inhibitors from March 2013 through January 2019
Physicians are aware of patients' difficulty with affording medical care and consider out-of-pocket costs in their decision making

Doctors Aware of Patient Difficulties Affording Medical Care

0
Three-quarters of doctors surveyed say they consider out-of-pocket costs when making clinical decisions
Health professionals are generally supportive of medicinal cannabis use but report a lack of knowledge about its use

Health Professionals Supportive of Medicinal Cannabis

0
However, across medicine, pharmacy, and nursing, providers need more information
In 2018

CDC: Uninsurance Levels Did Not Change Significantly in 2018

0
Uninsurance increased among adults aged 45 to 64 years; increase seen in high-deductible health plans
In 2018

2018 Saw More Employed Physicians Than Self-Employed

0
Proportion of physicians working in practices wholly owned by physicians dropped to 54 percent in 2018
Nasal high-frequency oscillatory ventilation reduces reintubation by more than 50 percent in preterm infants with respiratory distress syndrome

NHFOV Superior for Preventing Reintubation of Preemies

0
Findings strongest among very preterm infants with respiratory distress syndrome ready for extubation
In 2015 to 2016

In 2015 to 2016, 45.8 Percent of U.S. Population Used Rx Drugs

0
Prescription drug use increased with age, reaching 85.0 percent for those aged 60 years and older
The average price for single-source brand-name drugs is higher in the United States than in other countries

External Reference Pricing Could Cut Drug Costs in U.S.

0
Prices averaged 3.2 to 4.1 times higher in U.S.; differential varied from 1.3 to 70.1 for individual drugs
Efforts are needed to ensure all completed large trials are reported

Efforts Needed to Ensure Publication of All Trials

0
67 trials ID'd that were unreported for median of nine years after completion, with 87,883 participants